Načítá se...
Functional observation after morphine withdrawal: effects of SJP-005
RATIONALE AND OBJECTIVE: SJP-005 (ketotifen and ibuprofen) is being developed as a potential new treatment for opioid withdrawal. Three studies were conducted to evaluate the early phase (acute, day 1) and late phase (days 2–12) effects of SJP-005 on discontinuation-induced morphine withdrawal. METH...
Uloženo v:
| Vydáno v: | Psychopharmacology (Berl) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8139893/ https://ncbi.nlm.nih.gov/pubmed/33555386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-021-05771-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|